Adrian Thomas, M.D.

The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify gaps and set targets for the future. The Alliance’s reporting will provide timely and concrete insights to inform decision-making at global level and help to assess what are the key hurdles impeding action, and facilitate collaboration between the public and private sectors: https://www.amrindustryalliance.org/progress-report/. The second progress report will be launched in January 2020.

Founded in 1958, Project HOPE is a leader in global health development and emergency relief programs. An international nonprofit organization, we save lives and improve health, especially among women and children. We accomplish our mission by improving the knowledge, abilities and tools of the health workforce to deliver high quality health services to communities in need. With programs in more than 25 countries, we work at the epicenter of today’s greatest health challenges including infectious and chronic diseases, disasters and health crises, maternal, neonatal and child health and the policies that impact how health care is delivered.

The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify gaps and set targets for the future. The Alliance’s reporting will provide timely and concrete insights to inform decision-making at global level and help to assess what are the key hurdles impeding action, and facilitate collaboration between the public and private sectors: https://www.amrindustryalliance.org/progress-report/. The second progress report will be launched in January 2020.

The Stop TB Partnership is a United Nations organization, based in Geneva, Switzerland and a hosted entity of the United Nations Office for Project Services (UNOPS). Established in 2000, the Partnership aligns 1600 partner organizations (including international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector) all over the world, leading global advocacy to end tuberculosis (TB). Together with its partners, the Stop TB Partnership is a collective force that is transforming the fight against TB globally.

Were a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the worlds most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, youre agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.